Abstract
The capacity of 22,25-DAC, AY-9944 and triparanol to inhibit cholesterol biosynthesis from three precursors, mevalonate, 7-dehydrocholesterol and desmosterol, has been studied in rat liver homogenates.
Evidence is presented that, in vitro, 22,25-DAC, a potent inhibitor of the sterol Δ24-reductase, also inhibits the 7-dehydrocholesterol-Δ7-reductase system.
Similar content being viewed by others
Abbreviations
- 22,25-DAC (SC-11952):
-
20α-(2-dimethylaminoethyl)amino-5α-pregnan-3β-ol dihydrochloride
- AY-9944:
-
trans-1,4-bis (2-chlorobenzylaminomethyl)cyclohexane dihydrochloride triparanol (Mer-29), 1-[p-(β-diethylaminoethoxy)phenyl]-1-(p-tolyl)-2-(p-chlorophenyl) ethanol
- 20,25-DAC (SC-12937):
-
N-methyl-N-(3-dimethylamino) propyl-17β-aminoandrost-5-en-3β-ol
- Δ7-reductase:
-
7-dehydrocholesterol-Δ7-reductase
- Δ24-reductase:
-
24-dehydrosterol-Δ24-reductase
- MVA:
-
mevalonic acid
- HMGCoA:
-
hydroxymethylglutarylcoenzyme A
- DBED:
-
N,N′-dibenzylethylenediamine
References
Humber, L. G., M. Kraml and J. Dubuc, Biochem. Pharmacol.11, 755–760 (1962).
Humber, L. G., M. Kraml, J. Dubuc and R. Gaudry, J. Med. Chem.6, 210–212 (1963).
Dvornik, D. and M. Kraml, Proc. Soc. Exp. Biol. Med.112, 1012–1014 (1963).
Dvornik, D., M. Kraml, J. Dubuc, M. Givner and R. Gaudy, J. Am. Chem. Soc.85, 3309 (1963).
Morand, P., J. F. Bagli, M. Kraml and J. Dubuc, J. Med. Chem.7, 504–508 (1964).
Dvornik, D., M. Kraml and J. Dubuc, Proc. Soc. Exp. Biol. Med.116, 537–539 (1964).
Kraml, M., L. G. Humber, J. Dubuc and R. Gaudry, J. Med. Chem.7, 500–503 (1964).
Humber, L. G., C. I. Chappel, A. V. Marton, M. Kraml and J. Dubuc, J. Med. Chem.9, 329–337 (1966).
Steinberg, D., “Advances in Pharmacology,” Vol. 1, Academic Press, New York, and references cited therein.
Humber, L. G., J. Med. Chem.7, 826–830 (1964).
Kraml, M., J. F. Bagli and D. Dvornik, Biochem. Biophys. Res. Comm.15, 455–457 (1964).
Dvornik, D., M. Kraml and J. F. Bagli, J. Am. Chem. Soc.86, 2739–2741 (1964).
Dvornik, D., M. Kraml and J. F. Bagli, Biochemistry5, 1060–1064 (1966), and references cited therein.
Ranney, R. E., D. L. Cook, W. E. Hambourger and R. E. Counsell, J. Pharm. Exp. Ther.142, 132–136 (1963).
Givner, M. L. and D. Dvornik, Biochem. Pharmacol.14, 611–619 (1965).
Kandutsch, A. A., J. Biol. Chem.237, 358–363 (1962).
Niemiro, R. and R. Fumagalli, Biochim. Biophys. Acta98, 624–632 (1965).
Rodney, G., M. L. Black and O. D. Bird, Biochem. Pharmacol.14, 445–456 (1965).
Sachs, B. A. and L. Wolfman, Metabolism12, 608–617 (1963).
Schoenheimer, R. and W. M. Sperry, J. Biol. Chem.106, 745–760 (1934).
Moore, P. R. and C. A. Baumann, J. Biol. Chem.195, 615–622 (1952).
Idler, D. R. and C. A. Baumann, J. Biol. Chem.203, 389–396 (1953).
Cook, R. P., Analyst86, 373–381 (1961).
Pottier, J., Clin. Chim. Acta13, 341–348 (1966).
Dempsey, M. E., “Progress in Biochemistry and Pharmacology,” Vol. 2 (in press), Karger, Basel-New York, 1966.
Author information
Authors and Affiliations
About this article
Cite this article
Kraml, M., Dubuc, J. & Dvornik, D. Agents affecting lipid metabolism. XXVI. Specificity of some inhibitors of the late stages of cholesterol biosynthesis. Lipids 2, 5–7 (1967). https://doi.org/10.1007/BF02531992
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02531992